Switching from other agents to extended-release carbamazepine in bipolar disorder

被引:0
作者
Weisler, RH
机构
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Duke Univ, Raleigh, NC USA
关键词
carbamazepine; bipolar; switching;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:111 / 111
页数:1
相关论文
共 33 条
  • [21] Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations
    Ahmad, A
    Garnett, WR
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) : 1363 - 1368
  • [22] Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy
    Garnett, WR
    Levy, B
    McLean, AM
    Zhang, YX
    Couch, RA
    Rudnic, EM
    Pellock, JM
    Belendiuk, GW
    EPILEPSIA, 1998, 39 (03) : 274 - 279
  • [23] Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics
    Schreiner, Andreas
    Lahaye, Marjolein
    Peuskens, Joseph
    Naber, Dieter
    Dilbaz, Nesrin
    Millet, Bruno
    Franco, Manuel A.
    Rancans, Elmars
    Turczynski, Jacek
    Smeraldi, Enrico
    Lara, Elsa
    Neznanov, Nikolaj G.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (05) : 593 - 603
  • [24] Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy
    Lee, Sang-Ahm
    Heo, Kyoung
    Kim, Won-Joo
    Song, Hong-Ki
    Kim, Sung-Eun
    Kim, Sang-Ho
    No, Soon-Kee
    Lee, Byung-In
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2010, 19 (06): : 356 - 358
  • [25] Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosages
    Steinhoff, Bernhard J.
    Wendling, Anne-Sophie
    EPILEPSY RESEARCH, 2009, 87 (2-3) : 256 - 259
  • [26] Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study
    Daniel E. Casey
    William H. Carson
    Anutosh R. Saha
    Amy Liebeskind
    Mirza W. Ali
    Darlene Jody
    Gary G. Ingenito
    Psychopharmacology, 2003, 166 : 391 - 399
  • [27] Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study
    Casey, DE
    Carson, WH
    Saha, AR
    Liebeskind, A
    Ali, MW
    Jody, D
    Ingenito, GG
    PSYCHOPHARMACOLOGY, 2003, 166 (04) : 391 - 399
  • [28] Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia
    Moeller, Hans-Juergen
    Johnson, Sunny
    Mateva, Temenuzhka
    Brecher, Martin
    Svensson, Ola
    Miller, Frank
    Meulien, Didier
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (02) : 95 - 105
  • [29] Pharmacokinetics of carbamazepine from extended release dosage forms:: bioavailability/bioequivalence and in vitro-in vivo correlation studies
    Koester, LS
    Dalla Costa, T
    Bassani, VL
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2004, 14 (05) : 401 - 407
  • [30] KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
    Trinka, Eugen
    Marson, Anthony G.
    Van Paesschen, Wim
    Kalviainen, Reetta
    Marovac, Jacqueline
    Duncan, Benjamin
    Buyle, Sonja
    Hallstrom, Yngve
    Hon, Petr
    Muscas, Gian Carlo
    Newton, Mark
    Meencke, Heinz-Joachim
    Smith, Philip E.
    Pohlmann-Eden, Bernd
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (10) : 1138 - 1147